CYCN
#4611
Cyclerion Therapeutics, Inc. - Common Stock
3.7 9 USD
-0.05%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-5.01%
Monthly Change
+8.29%
6 month change
+189.31%
Year Change
+51.60%
Previous Close
3.9 9
Open
3.7 9
Low
3.7 9
High
3.7 9
Volume
1
Financials
- Market Capitalization 17.74 M
- Employee 1
- Founded 2018
- CEO N/A
- Website www.cyclerion.com
- Headquarter Massachusetts, United States
- FIGI BBG00KXXHYD9
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.14
Price to sales ratio
1.95
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4596 |  RADX Radiopharm Theranostics Limited American Depositary Shares | 2.41 USD | +6.64% | -0.82% | -23.49% | -56.18% | 19.00 M USD | ||
| 4609 |  BCDA BioCardia, Inc. - Common Stock | 1.18 USD | +0.85% | +18.00% | +49.37% | +2.16% | 17.86 M USD | ||
| 4615 |  LPCN Lipocine Inc. - Common Stock | 2.17 USD | -2.69% | +4.83% | +5.85% | -25.17% | 17.89 M USD | ||
| 4620 |  LEXX Lexaria Bioscience Corp. - Common Stock | 10.37 USD | -11.22% | -5.38% | +1894.23% | +1065.17% | 17.14 M USD |
Frequently asked questions about Cyclerion Therapeutics, Inc. Common Stock
What is the Cyclerion Therapeutics, Inc. Common Stock stock price today?
The current price of Cyclerion Therapeutics, Inc. Common Stock (CYCN) is 3.79. Over the past 24 hours, the stock has changed by -5.01%. Follow the CYCN chart for real-time price dynamics.
What is the stock ticker of Cyclerion Therapeutics, Inc. Common Stock?
Cyclerion Therapeutics, Inc. Common Stock trades under the ticker CYCN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Cyclerion Therapeutics, Inc. Common Stock stock going up?
CYCN has changed by -5.96% over the last week, +8.29% over the last month, and +51.60% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Cyclerion Therapeutics, Inc. Common Stock?
Cyclerion Therapeutics, Inc. Common Stock currently has a market capitalization of 17.74 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Cyclerion Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Cyclerion Therapeutics, Inc. Common Stock reported earnings of -0.41 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Cyclerion Therapeutics, Inc. Common Stock revenue for the last quarter?
Cyclerion Therapeutics, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Cyclerion Therapeutics, Inc. Common Stock net income for the last quarter?
Cyclerion Therapeutics, Inc. Common Stock reported net income of -1.75 M for the last quarter. The previous quarter showed -3.18 M, which means net income changed by +44.76%.
How many employees does Cyclerion Therapeutics, Inc. Common Stock have?
As of the latest available data, Cyclerion Therapeutics, Inc. Common Stock has 1 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Cyclerion Therapeutics, Inc. Common Stock stock?
You can buy Cyclerion Therapeutics, Inc. Common Stock (CYCN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Cyclerion Therapeutics, Inc. Common Stock stock?
Investing in Cyclerion Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CYCN chart and related analysis on metatrader.com as part of your research.